Kenneth E. Sherman - Concepedia

Author

Kenneth E. Sherman

University of Cincinnati Medical Center ORCID

Also Known As

Colquhoun, Dodi, Everson, Gregory T., For the ACTG 5294 BIRTH Study Team, K E Sherman, K Sherman, K. E. SHERMAN, K. E. Sherman, K.E. Sherman, K. E. Sherman, KENNETH E. SHERMAN

346

Publications

14.6K

Citations

H-Index

172

Concepts

All Affiliations

University of Cincinnati Medical Center University of Cincinnati Harvard University Massachusetts General Hospital University of California, San Francisco

About

Kenneth E. Sherman is an author at University of Cincinnati Medical Center specializing in medicine, hepatitis, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	74	6.1K
2	Public Health	11	12	1.4K
3	Health Sciences	6	7	991
4	Arts	1	1	11
5	Social Sciences	1	1	11

Kenneth E. Sherman

161

Publications

11.6K

Citations

H-Index

Page 1

	Year	Citations
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons Raymond T. Chung, Janet Andersen, Paul A. Volberding, New England Journal of Medicine	2004	873
Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection Kenneth E. Sherman, Steven L. Flamm, Nezam H. Afdhal, New England Journal of Medicine	2011	744
Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group Kenneth E. Sherman, Susan D. Rouster, Raymond T. Chung, Clinical Infectious Diseases Hepatitis C VirusAntiviral DrugHuman Immunodeficiency VirusViral HepatitisHuman Retrovirus	2002	731
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1 David Wyles, Peter Ruane, Mark Sulkowski, New England Journal of Medicine	2015	418
Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections Kenneth E. Sherman, Julia O’Brien, A G Gutierrez, Journal of Clinical Microbiology	1993	233
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection Norah A. Terrault, Michelle E. Roland, Thomas D. Schiano, Liver Transplantation Hcv PatientsTransplantationHepatologyHepatitis CKidney Transplant	2012	214
Serum bilirubin levels in the U.S. Population: Gender effect and inverse correlation with colorectal cancer Stephen D. Zucker, Paul S. Horn, Kenneth E. Sherman Hepatology NutritionImmunohematologyIron MetabolismEpidemiology Of CancerCholangiopathies	2004	211
Serum bilirubin levels in the U.S. population: Gender effect and inverse correlation with colorectal cancer Stephen D. Zucker, Paul S. Horn, Kenneth E. Sherman Hepatology NutritionBile PigmentEpidemiology Of CancerCholangiopathiesBody Composition	2004	201

Page 1